Global preventive medicine market projected to reach USD 870.06 billion by 2033, with North America leading.

From GlobeNewswire: 2024-08-25 04:00:00

The Global Preventive Medicine Market is projected to reach USD 870.06 billion by 2033 with a CAGR of 8.20%. Preventive medicine focuses on preventing diseases through interventions like immunizations and screenings, aiming to improve health outcomes and reduce healthcare costs. The market faces challenges like high initial costs and limited healthcare access.

Key segments in the preventive medicine market include early detection and screening, personalized medicine, chronic disease management technologies, occupational medicine, and aerospace medicine. Early detection and screening are expected to hold the largest market share due to their role in detecting health issues early for timely intervention and improved outcomes. Hospitals dominate the distribution channels due to their comprehensive healthcare services and technology.

North America is predicted to lead the preventive medicine market driven by modern healthcare infrastructure and government support. Asia Pacific is expected to have the highest CAGR growth due to rising healthcare spending and public awareness of preventative measures. Major players in the market include Novo Nordisk, GlaxoSmithKline, and Abbott Laboratories among others.

Recent developments in the market include IHI’s new Alzheimer’s program and Andhra Pradesh’s healthcare project. The market is segmented by type, distribution channels, and region, with forecasts up to 2033. Spherical Insights provides in-depth analysis of key companies, market trends, and developments to inform strategic decision-making.



Read more at GlobeNewswire: Global Preventive Medicine Market Size To Worth USD 870.06